Oncology - European Medical Journal

Continue

Oncology

Filter
4 Jan 2018

FDA Designation Given to Combination Treatment in Pre-Menopausal Women with Advanced Breast Cancer

FDA Breakthrough Therapy designation has been given for a combination therapy used as an initial treatment for pre-menopausal women with HR+/HER2-…
3 Jan 2018

New Method Could Lead to Early Diagnosis and Treatment of Breast Cancer

FATAL breast cancer can be diagnosed up to 1 year earlier than current diagnosis methods by finding a region of DNA in the blood, according to…
19 Dec 2017

Immune Cells Facilitating Cancer Spread May Offer Treatment Route

IMMUNE CELLS have been found to aid in the metastasis of prostate cancer, according to new research from the University of Michigan, Ann Arbor, Michigan…
5 Dec 2017

Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint® BluePrint® Breast Cancer Kit Co-Validation Study

Agendia, a world leader in personalized medicine and molecular cancer diagnostics, and Institute Curie in Paris, France…
1 Dec 2017

New Data at the San Antonio Breast Cancer Symposium Demonstrate the Value of MammaPrint® and BluePrint® Across Breast Cancer Patient Populations

Irvine, CA, USA and Amsterdam, the Netherlands, 30 November, 2017 – Agendia, Inc., a world leader in personalized medicine…
1 Dec 2017

Eye Contact Establishes Brainwave Synchronisation Between Adults and Babies

BRAINWAVES of adults and babies are synchronised when eye contact is made between the two, which is likely to enhance communication and learning…
30 Nov 2017

SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer

Prague, Czech Republic, 28 November, 2017 – SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient…
23 Nov 2017

Treatment Approval Broadened to Include Earlier Stage Prostate Cancer Patients

AN UNMET need in prostate cancer patients could be filled following the extension of European Commission (EC) marketing authorisation of the combination…